UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Chest, ISSN 0012-3692, 01/2001, Volume 119, Issue 1, pp. 64S - 94S
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Heparin, Low-Molecular-Weight - pharmacology | Venous Thrombosis - drug therapy | Humans | Heparin, Low-Molecular-Weight - adverse effects | Anticoagulants - therapeutic use | Heparin - therapeutic use | Anticoagulants - adverse effects | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Heparin, Low-Molecular-Weight - pharmacokinetics | Myocardial Infarction - drug therapy | Angina, Unstable - drug therapy | Anticoagulants - pharmacology | Coronary Disease - drug therapy | Venous Thrombosis - prevention & control | Anticoagulants - pharmacokinetics | Heparin - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2004, Volume 126, Issue 3, pp. 188S - 203S
Pentasaccharide | Heparin | Low-molecular-weight heparin | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Pneumology | Drug Administration Schedule | Humans | Heparin, Low-Molecular-Weight - adverse effects | Biological Availability | Heparin - therapeutic use | Hemorrhage - blood | Evidence-Based Medicine | Heparin - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Heparin - pharmacokinetics | Metabolic Clearance Rate - physiology | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Hemorrhage - drug therapy | Fibrinolytic Agents - pharmacokinetics | Kidney Failure, Chronic - blood | Partial Thromboplastin Time | Fibrinolytic Agents - therapeutic use | Antithrombin III - metabolism | Protamines - therapeutic use | Hemorrhage - chemically induced | Heparin Antagonists - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
Cochrane library, ISSN 1469-493X, 04/2017, Volume 2017, Issue 4, pp. CD007557 - CD007557
Thrombocytopenia | Anticoagulants | Heparin_induced thrombocytopenia (HIT) | Surgical Procedures, Operative | Medical prophylaxis | Medical treatment | Venous Thrombosis | Deep vein thrombosis | Heparin, Low‐Molecular‐Weight | Thrombosis | Randomized Controlled Trials as Topic | Pulmonary embolism | Prevention | Pulmonary Embolism (PE) | Blood disorders | Numbers Needed To Treat | Treatment | Deep vein thrombosis (DVT) related | Prevention: medical approaches | Heparin | Heart & circulation | Medicine General & Introductory Medical Sciences | Thromboembolism | Postoperative Complications | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anticoagulants - administration & dosage | Humans | Postoperative Complications - prevention & control | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Surgical Procedures, Operative - statistics & numerical data | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Thrombocytopenia - complications | Venous Thrombosis - etiology | Thrombosis - etiology | Thrombocytopenia - prevention & control | Venous Thrombosis - prevention & control | Heparin, Low-Molecular-Weight - administration & dosage | Thrombosis - prevention & control | Postoperative Complications - chemically induced | Index Medicus
Journal Article
Annals of internal medicine, ISSN 0003-4819, 05/1999, Volume 130, Issue 10, pp. 800 - 809
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Blood. Blood coagulation. Reticuloendothelial system | Pharmacology. Drug treatments | Recurrence | Double-Blind Method | Venous Thrombosis - drug therapy | Humans | Venous Thrombosis - mortality | Heparin, Low-Molecular-Weight - adverse effects | Anticoagulants - therapeutic use | Heparin - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Heparin, Low-Molecular-Weight - therapeutic use | Randomized Controlled Trials as Topic | Analysis of Variance | Sensitivity and Specificity | Hemorrhage - chemically induced | Research Design | Index Medicus | Abridged Index Medicus
Journal Article